BREAKING NEWS

FDA approves axitinib for renal cell carcinoma

The FDA today approved axitinib tablets for use in patients with previously treated advanced renal cell carcinoma.

The FDA approved axitinib (Inlyta, Pfizer) based on a single international, randomized, open-label trial involving patients with advanced renal cell carcinoma after failure of one prior systemic regimen.

Full story

January 26 - 29, 2012

10th International Medical Symposium on VHL

Houston, TX

February 02 - 04, 2012

2012 Genitourinary Cancers Symposium

San Francisco, CA

February 02 - 04, 2012

The 14th International Symposium on Anti-Angiogenic Therapy: Recent Advances and Future Directions in Basic and Clinical Cancer Research; San Diego

San Diego, CA

Intraarterial Therapy to the Limb and Liver

Presented by: Jonathan S. Zager, MD
at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting

More

Innovations in caring for the patient with advanced cancer


Stephanie M. Harman, MD, FACP

When I hear the word “innovation,” too often it is associated only with a technological wonder, such as a new stent or catheter. This past spring, Frontiers of Health Services Management published an issue that explored innovations in how we care for our sickest patients. A program by Aetna, in which hospice benefits were “expanded” for Medicare patients, was among those highlighted.

Full story